Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 161 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Associates In Womens Health — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute LAO
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
AMR Clinical — El Dorado, Kansas (27.8 mi)
· Sponsor: Eli Lilly and Company
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Ascension Via Christi Saint Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Medtronic Cardiovascular
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Ascension via Christi Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Procyrion
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Global Paradise System US Post Approval Study
Hypertension, Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Ascension via Christi St. Francis — Wichita, Kansas (0.4 mi)
· Sponsor: ReCor Medical, Inc.
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Paradigm Health
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Local Institution - 0165 — Wichita, Kansas (0.4 mi)
· Sponsor: Bristol-Myers Squibb
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Wesley Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Orchestra BioMed, Inc
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Kansas Gastroenterology, LLC under Clinical Trials Network — Wichita, Kansas (0.4 mi)
· Sponsor: Hoffmann-La Roche
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
AMR Clinical - El Dorado — El Dorado, Kansas (27.8 mi)
· Sponsor: Housey Healthcare ULC
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Type 2 Diabetes
N/A
Observational 2,150 participants sought
Research Site — El Dorado, Kansas (27.8 mi)
· Sponsor: AstraZeneca
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Shockwave Medical, Inc.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Kansas Nephrology Physicians, PA — Wichita, Kansas (0.4 mi)
· Sponsor: CSL Behring
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Chondral Defect, Articular Cartilage Defect
Phase 3
Interventional 309 participants sought
Elevate Clinical Research Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Vericel Corporation
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
Integrity Clinical Network, LLC — Derby, Kansas (10.8 mi)
· Sponsor: Pfizer